Skip to main content
Morepen Laboratories Ltd. logo

Morepen Laboratories Ltd. — Investor Relations & Filings

Ticker · MOREPENLAB ISIN · INE083A01026 LEI · 335800OJZDFHFQJ4HP35 BSE.NS Manufacturing
Open in API
Filings indexed 1,660 across all filing types
Latest filing 2024-09-28 Declaration of Voting R…
Country IN India
Listing BSE.NS MOREPENLAB

About Morepen Laboratories Ltd.

https://www.morepen.com

Morepen Laboratories Ltd. is a research-led company specializing in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), home diagnostic devices, and finished formulations. The company maintains a significant global presence, exporting high-quality APIs such as Loratadine, Montelukast, Atorvastatin, and Fexofenadine to numerous international markets. Its diagnostic division, branded as Dr. Morepen, is a prominent player in the home healthcare segment, offering a wide range of products including digital glucometers, blood pressure monitors, and nebulizers. Morepen operates manufacturing facilities compliant with international regulatory standards, including USFDA approvals. The company focuses on leveraging its R&D capabilities to deliver healthcare solutions and maintains a diverse portfolio across various therapeutic areas including cardiovascular, anti-diabetic, and anti-asthmatic treatments.

Recent filings

Filing Released Lang Actions
Please find enclosed e-Voting results along-with scrutinizer''s report for the 39th Annual General Meeting held on Saturday, 28th September 2024 at 1.00 pm through VC/ OAVM.
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is dated 28/09/2024 and is addressed to stock exchanges (NSE and BSE) regarding the voting results of the 39th Annual General Meeting (AGM) held on the same date via video conferencing. It references the Companies Act, 2013, SEBI Listing Obligations & Disclosure Requirements Regulations, and details the e-voting process, scrutinizer appointment, and consolidated voting results for multiple resolutions including adoption of financial statements, director appointments, and remuneration ratification. The document includes detailed voting statistics and confirms the results are posted on the company and NSDL websites. The content is focused on the official announcement of shareholder voting outcomes at the AGM, not the AGM materials or the full annual report itself. The document length is about 14,902 characters, which is substantial but the content is clearly a formal announcement of voting results. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-09-28 English
Please find enclosed proceedings of the 39th Annual General Meeting held through VC/ OAVM on Saturday, 28th September 2024 at 1.00 p.m. (IST).
AGM Information Classification · 95% confidence The document is titled 'Proceedings of 39th Annual General Meeting' and details the summary of the AGM held on 28th September 2024. It includes information about the meeting's conduct, the chairman, quorum, agenda items such as adoption of audited financial statements, appointment and re-appointment of directors, and voting procedures. It explicitly states it is a summary of the AGM proceedings and not the minutes or the full report. The document is about the meeting proceedings and not the full Annual Report or financial statements themselves. Therefore, it fits the category of AGM Information (AGM-R). The document length is 6860 characters, which is consistent with a detailed meeting summary rather than a brief announcement or a full report. Hence, the classification is AGM-R with high confidence.
2024-09-28 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is titled 'Proceedings of 39th Annual General Meeting' and details the summary of the AGM held on 28th September 2024. It includes information about the meeting's conduct, the chairman's address, the agenda items considered (such as adoption of audited financial statements, appointment and re-appointment of directors, and ratification of remuneration), and voting procedures. The document explicitly states it is a summary of the AGM proceedings and not the minutes. There is no detailed financial data or full report content, but rather a record of the meeting's events and resolutions discussed. This matches the definition of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting. The document is over 5,000 characters and contains substantive content about the meeting proceedings, not just an announcement or a brief note. Therefore, the correct classification is AGM-R with high confidence.
2024-09-28 English
Please find enclsoed intimation w.r.t., appointment of Mr. Amrit Ravi as ''Lead - Emerging Opportunities'' in the grade of Vice President, being a Senior Management Personnel.
Board/Management Information Classification · 100% confidence The document is a formal disclosure submitted to stock exchanges (NSE and BSE) under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements. It announces the appointment of a senior management personnel, Mr. Amrit Ravi, as Lead - Emerging Opportunities, effective October 1, 2024. The document includes details required by SEBI regulations about the appointment, such as the reason for change, date of appointment, brief profile, and relationship disclosures. There is no financial data, earnings information, or report content. The document is clearly an announcement of a management change, not a full report or financial filing. Therefore, it fits the category of Board/Management Information (MANG).
2024-09-27 English
Appointment
Board/Management Information Classification · 100% confidence The document is a formal disclosure submitted to stock exchanges (NSE and BSE) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It announces the appointment of a senior management personnel, Mr. Amrit Ravi, as 'Lead - Emerging Opportunities' effective October 1, 2024. The document includes details required by SEBI circular dated July 13, 2023, about the appointment, including the profile of the appointee. There are no financial statements, earnings data, or report attachments. The content is clearly about a change in senior management personnel, which fits the category of Board/Management Information (MANG). The document length is about 4,823 characters, which is consistent with a detailed announcement rather than a full report. Therefore, the correct classification is MANG with high confidence.
2024-09-27 English
Please find attached letter w.r.t., closure of trading window w.e.f., 1st October 2024 till the 48 hours from the announcement of financial results for the quarter and half year ended on ....
Regulatory Filings Classification · 95% confidence The document is a formal notice from Morepen Laboratories Limited addressed to stock exchanges regarding the closure of the trading window. It references SEBI regulations on insider trading and states that the trading window will be closed from October 1, 2024, until 48 hours after the announcement of unaudited financial results for the quarter and half year ended September 30, 2024. The document does not contain any financial data, results, or detailed report content but is an announcement related to trading restrictions ahead of financial results disclosure. The document length is short (1963 characters), and it serves as a regulatory compliance notice rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such compliance and regulatory announcements that do not fit other specific categories.
2024-09-27 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.